How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer.

Katalin BoérAmbrus KaposiJudit KocsisZsolt HorváthBalázs MadarasÁkos SávoltGyorgy Benjamin KlémentGabor Rubovszky

Published in: Cancers (2024)

The Oncotype DX test substantially improves decision accuracy in recommending adjuvant chemotherapy. It may be further improved with a consensus decision. In the case of pre-RS consensus against chemotherapy, the test can be spared.

Keyphrases

early stage
clinical practice
decision making
neuropathic pain
locally advanced
sentinel lymph node
lymph node
neoadjuvant chemotherapy